MODEL-AD AAIC 2023 Presentations
Presentation # Session Title, Date & Time Presentation Title Presenting Author Poster #70759 P1-09 [In-Person Posters Sun] Biomarkers: Neuroimaging Sunday, July 16, 2023: 8:45 AM – 4:15 PM CEST A novel 3D imaging method to establish baseline amyloid-beta plaque...
Computational techniques and resources to characterize translational relevance of model organisms in Alzheimer’s Disease
JAX Genomic Medicine Farmington, Connecticut Thursday, June 15, 9am-5pm This workshop aims to accelerate targeted use of Alzheimer’s Disease (AD) mouse models in preclinical studies by providing participants with hands-on training on computational approaches for...
Meeting report of the annual workshop on Principles and Techniques for Improving Preclinical to Clinical Translation in Alzheimer’s Disease research
Meeting report of the annual workshop on Principles and Techniques for Improving Preclinical to Clinical Translation in Alzheimer's Disease research Sasner J, Territo PR, Sukoff Rizzo SJ https://pubmed.ncbi.nlm.nih.gov/37070936/
STOP-AD portal: Selecting the optimal pharmaceutical for preclinical drug testing in Alzheimer’s disease
STOP-AD portal: Selecting the optimal pharmaceutical for preclinical drug testing in Alzheimer's disease Quinney SK, Murugesh K, Oblak A, Onos KD, Sasner M, Greenwood AK, Woo KH, Sukoff Rizzo SJ, Territo PR https://pubmed.ncbi.nlm.nih.gov/37157089/
Differential splicing of neuronal genes in a Trem2*R47H mouse model mimics alterations associated with Alzheimer’s disease
Differential splicing of neuronal genes in a Trem2*R47H mouse model mimics alterations associated with Alzheimer’s disease. Pandey RS, Kotredes KP, Sasner M, Howell GR, Carter GW. https://bmcgenomics.biomedcentral.com/articles/10.1186/s12864-023-09280-x
MODEL-AD presentations at ADPD 2023
SYMPOSIUM--TRANSLATIONAL DRUG DISCOVERY: THE VALUE OF ANIMAL MODELS AND ORGANOIDS Wednesday March 29 HALL G3 14:45-15:00 MODELING LATE-ONSET ALZHEIMER’S DISEASE IN MICE SYMPOSIUM--SELECTIVE VULNERABILITY, GLIAL CELLS AND MECHANISMS OF NEURDEGENERATION Wednesday March...
MODEL-AD Presentations at SfN 2022: Visit us at Booth #3418
Abstract Title Authors Session # Session Day & Time Methodology To Objectively Prioritize Therapeutic Hypotheses in Alzheimer’s Disease Via Target Risk Scoring and Biological Domain Annotation S.Keegan, J. Wiley, G. Cary, J. Gockley, J. Liu, L. Heath, A....
Funding Opportunity: ALZ Discovery Grant Program
Alzheimer’s Association Leveraging Model & Data Resources to Advance Alzheimer’s and Dementia Discovery Program (ALZ Discovery Grant Program) The Alzheimer’s Association ALZ Discovery Grant Program will fund projects that leverage and utilize data sets such as...